Score Overview
Explore the 2021 public Archive ranking →
Where Trinity Biotech plc has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 30 years of fundamentals. TRIB does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 6.43 | — |
1 Year2025-09-30 | $ 31.20 | -79.39% |
5 Years2021-09-30 | $ 324.00 | -98.02% |
10 Years2016-09-30 | $ 1.98K | -99.68% |
20 Years2006-09-29 | $ 1.32K | -99.51% |
30 Years1996-09-30 | $ 1.91K | -99.66% |
All Time1995-08-18 | $ 1.35K | -99.52% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | 20 Years2006-09-29 | 30 Years1996-09-30 | All Time1995-08-18 |
|---|---|---|---|---|---|---|---|
| Price | $ 6.43 | $ 31.20 | $ 324.00 | $ 1.98K | $ 1.32K | $ 1.91K | $ 1.35K |
| Return | — | -79.39% | -98.02% | -99.68% | -99.51% | -99.66% | -99.52% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 52M | -$ 35M | $ 1M |
| 2024 | $ 61M | -$ 31M | $ 5M |
| 2023 | $ 56M | -$ 24M | $ 3M |
| 2022 | $ 62M | -$ 41M | $ 6M |
| 2021 | $ 81M | $ 875K | $ 25M |
| 2020 | $ 101M | -$ 6M | $ 27M |
| 2019 | $ 90M | -$ 4M | $ 16M |
| 2018 | $ 97M | $ 2M | $ 30M |
| 2017 | $ 99M | -$ 40M | $ 57M |
| 2016 | $ 99M | -$ 100M | $ 77M |
| 2015 | $ 100M | $ 21M | $ 101M |
| 2014 | $ 104M | $ 17M | $ 9M |
| 2013 | $ 91M | $ 10M | $ 22M |
| 2012 | $ 82M | $ 17M | $ 74M |
| 2011 | $ 77M | $ 15M | $ 71M |
| 2010 | $ 89M | $ 60M | $ 58M |
| 2009 | $ 125M | $ 11M | $ 6M |
| 2008 | $ 140M | -$ 77M | $ 5M |
| 2007 | $ 143M | -$ 35M | $ 8M |
| 2006 | $ 118M | $ 3M | $ 2M |
| 2005 | $ 98M | $ 5M | $ 9M |
| 2004 | $ 79M | $ 5M | $ 22M |
| 2003 | $ 65M | $ 5M | $ 20M |
| 2002 | $ 51M | $ 5M | $ 5M |
| 2001 | $ 37M | $ 1M | $ 5M |
| 2000 | $ 29M | $ 4M | $ 4M |
| 1999 | $ 26M | $ 4M | $ 3M |
| 1998 | $ 23M | $ 2M | $ 1M |
| 1997 | $ 16M | $ 1M | $ 2M |
| 1996 | $ 7M | -$ 900K | $ 4M |
| IPO1995 | $ 9M | -$ 800K | $ 7M |
Trinity Biotech plc fundamental performance
Between 2004 and 2024, revenue declined from $ 79M to $ 61M and net income went from $ 5M to -$ 31M. Revenue increased in 7 of those 20 years; net income in 9.
Across Trinity Biotech plc's full reported history, from 1995 to 2024, revenue grew from $ 9M to $ 61M and net income went from -$ 800K to -$ 31M. Revenue increased in 53% of the years measured; net income in 50%.
Trinity Biotech plc currently holds a 20-year HDB Score of 2.4 out of 10. How the HDB Score is calculated.
Membership
Explore TRIB with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
